Terminated PHASE3 INTERVENTIONAL 2-arm NCT00945399

Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions

Phase III Protocol Comparing a Microfracture Treatment to a CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions

Sponsor: TBF Genie Tissulaire

Conditions Knee Chondral Osteochondral Defect

Interventions CARTIPATCH® procedure Microfracture

Updated 6 times since 2017 Last updated: Apr 25, 2015 Started: Oct 31, 2008 Primary completion: Jul 31, 2012 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Manufacturing stopped

Other terminated trials from TBF Genie Tissulaire

See all terminations from TBF Genie Tissulaire

This PHASE3 trial investigates Knee Chondral and Osteochondral Defect and is currently terminated or withdrawn. TBF Genie Tissulaire leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

TBF Genie Tissulaire

Data source: TBF Genie Tissulaire

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ghent, Belgium